ES8502093A1 - Derivados de quinolina. - Google Patents

Derivados de quinolina.

Info

Publication number
ES8502093A1
ES8502093A1 ES522089A ES522089A ES8502093A1 ES 8502093 A1 ES8502093 A1 ES 8502093A1 ES 522089 A ES522089 A ES 522089A ES 522089 A ES522089 A ES 522089A ES 8502093 A1 ES8502093 A1 ES 8502093A1
Authority
ES
Spain
Prior art keywords
radical
quinoline derivatives
formula
cyclopropyl
mean
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522089A
Other languages
English (en)
Spanish (es)
Other versions
ES522089A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838302236A external-priority patent/GB8302236D0/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES522089A0 publication Critical patent/ES522089A0/es
Publication of ES8502093A1 publication Critical patent/ES8502093A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES522089A 1982-05-04 1983-05-04 Derivados de quinolina. Expired ES8502093A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8212787 1982-05-04
GB838302236A GB8302236D0 (en) 1983-01-27 1983-01-27 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
ES522089A0 ES522089A0 (es) 1984-12-16
ES8502093A1 true ES8502093A1 (es) 1984-12-16

Family

ID=26282723

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522089A Expired ES8502093A1 (es) 1982-05-04 1983-05-04 Derivados de quinolina.

Country Status (13)

Country Link
US (1) US4607039A (en22)
EP (1) EP0093521B1 (en22)
KR (1) KR840004726A (en22)
DD (1) DD209817A5 (en22)
DE (1) DE3377796D1 (en22)
DK (1) DK199183A (en22)
ES (1) ES8502093A1 (en22)
FI (1) FI831537A7 (en22)
GB (1) GB8310261D0 (en22)
GR (1) GR78484B (en22)
IL (1) IL68513A0 (en22)
NO (1) NO831562L (en22)
PT (1) PT76630B (en22)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
JPH064584B2 (ja) * 1984-02-29 1994-01-19 沢井製薬株式会社 新規アニリド誘導体
US5179107A (en) * 1990-09-07 1993-01-12 Schering Corporation Antiviral quinolinone compounds
US5190956A (en) * 1990-09-07 1993-03-02 Schering Corporation Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infections
EP0549729B1 (en) * 1990-09-07 1997-12-17 Schering Corporation Antiviral compounds and antihypertensive compounds
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
FR2795645B1 (fr) * 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
MY120631A (en) * 2000-09-08 2005-11-30 Union Pharma Scient Appl Novel pharmaceutical combination having analgesic activity
WO2007089634A2 (en) * 2006-01-30 2007-08-09 Merck & Co., Inc. Inhibitors of fatty acid synthase (fas)
US8680116B2 (en) * 2009-07-22 2014-03-25 Merck Sharp & Dohme Corp. Quinolinone PDE2 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US16394A (en) * 1857-01-13 Improvement in gotton-gins
DE430960C (de) * 1924-07-11 1926-06-23 J G Farbenindustrie Akt Ges Verfahren zur Darstellung von basischen AEthern von Chinolinderivaten
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
US1860286A (en) * 1929-05-16 1932-05-24 Soc Of Chemical Ind Basic ethers of aryl-quinolines
GB349761A (en) * 1929-05-16 1931-06-04 Chem Ind Basel Manufacture of aminoalkoxy-derivatives of aryl-quinolines
US4035374A (en) * 1973-05-03 1977-07-12 Smith Kline & French Laboratories Limited Imidazolyl alkylaminopyridone and pyridinethione compounds
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
US4235909A (en) * 1979-04-19 1980-11-25 Eli Lilly And Company Octahydro-2H-pyrrolo[3,4-g]quinolines
GR73576B (en22) * 1980-03-01 1984-03-20 Wyeth John & Brother Ltd
IN158970B (en22) * 1981-06-09 1987-02-28 Ici Plc

Also Published As

Publication number Publication date
KR840004726A (ko) 1984-10-24
ES522089A0 (es) 1984-12-16
PT76630B (en) 1985-12-03
NO831562L (no) 1983-11-07
FI831537L (fi) 1983-11-05
DE3377796D1 (en) 1988-09-29
PT76630A (en) 1983-06-01
GR78484B (en22) 1984-09-27
DK199183A (da) 1983-11-05
EP0093521A3 (en) 1984-08-01
FI831537A0 (fi) 1983-05-04
US4607039A (en) 1986-08-19
IL68513A0 (en) 1983-07-31
FI831537A7 (fi) 1983-11-05
DD209817A5 (de) 1984-05-23
EP0093521B1 (en) 1988-08-24
GB8310261D0 (en) 1983-05-18
DK199183D0 (da) 1983-05-04
EP0093521A2 (en) 1983-11-09

Similar Documents

Publication Publication Date Title
ES8502093A1 (es) Derivados de quinolina.
SE416970C (sv) Sett for att behandla eller bestryka ytor, exempelvis lopande materialbanor
SE8100978L (sv) Kinolinkarboxylsyraderivat och sett for framstellning derav
FI834806A0 (fi) 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7-(alkyl)-1-piperazinyl)-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella produkter
FR2416222A1 (fr) Derives perfluoroalkyl-thioethyl-ether
FR2387968A1 (fr) Derives soufres du 1,2,4-triazole, utilisables comme additifs de lubrifiants
FR2357553A1 (fr) Procede de preparation de benzothiazoles
DK603983A (da) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(4-(oxoalkyl)-1-piperazinyl)-3-quinolincarboxylsyre og derivater deraf, fremgangsmaader til fremstilling deraf samt antibakterielle midler med indhold af disse forbindelser
FR2367059A1 (fr) Additifs pour lubrifiants
ES348783A1 (es) Procedimiento para la preparacion de derivados de acido a- rilacrilico.
MX7260E (es) Procedimiento para preparar derivados de sacarosa 4'halo-substituidos
KR890003668A (ko) 플루오르화 벤조일 화합물
ES539160A0 (es) Un procedimiento para preparar derivados de penem
ATE61353T1 (de) 2,3-diaminoacrylonitrilderivate.
FI810145L (fi) Nya substituerade 1,8-dihydroxi-9-(10h)antracenoner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
IT1114314B (it) Composizioni a base di alchenilsuccinimmidi derivate dalla tris(ammino-5 tia-3 pentil)ammina loro procedimento di preparazione e loro applicazione come additivi per lubrificanti
MX149874A (es) Procedimiento mejorado para el tratamiento de un destilado de petroleo que contiene mercaptanos
GB2021586A (en) 1,2,4-Triazolidin-3-ones (and -thiones)
FR2398752A1 (fr) Esters tetracarboxyliques de 2,2,6,6-tetramethyl-piperidino-spiro-dioxanol
FR2378519A1 (en22)
SE8101733L (sv) Herbicida 2-haloacetamider
DK515280A (da) Silylbenzimidazol-2-carbamidsyreestere fremgangsmaade til fremstilling heraf samt anvendelse af disse forbindelser som fungicider
ES8200114A1 (es) Procedimiento de obtencion de compuestos de monoorgano tris-trialquilestano
SE8302084L (sv) Nya bensimidazolderivat
UA9123A1 (uk) 1-гідроксіетил-3,5-бісгідроксиметил-1,3,5-гексагідротріазиhоh-4 як аhтимікробhа добавка для боротьби з біологічhим пошкоджеhhям мастильhо-охолоджувальhих емульсій